gastrointestinal Applications
-
Premium
Activated carbons solutions for medicinal and pharmaceutical industry
Modern medical treatments increasingly utilise drug therapy in addition to, or in place of, invasive measures. The growth of new pharmaceutical preparations is today at an unprecedented level. At the same time, increasing regulatory scrutiny over pharmaceutical formulations adds to the challenge for pharmaceutical companies. Jacobi has extensive knowledge of the regulatory and economic challenges faced by pharmaceutical manufacturers, and deep insight into their complex markets. Regardless of the industry sector ...
By Jacobi Group based in Kalmar, SWEDEN.
-
Boric Acid for Effects Humans
, for children of 5-6 g, adult for 15 to 20 g, clinical manifestation, may have gastrointestinal mucosa ...
By Xi`an Unique Electronic & Chemical Co., Ltd. based in Yanta District, CHINA.
-
Boric Acid for Toxicity
) can be absorbed quickly from gastrointestinal tract, serous cavity and damaged skin, so it ...
By Xi`an Unique Electronic & Chemical Co., Ltd. based in Yanta District, CHINA.
-
Single Use Linear Cutting Staple for GIA
, obstetrics, and gynecology, such as lobectomy, gastrointestinal anastomosis, etc. GIA stapling device ...
By Victor Medical Instruments Co., Ltd based in Changzhou, CHINA.
-
Activated carbon and activated charcoal solutions for pharma industry
Pharma Industry offers many Applications for our Activated Carbon products. We as one of the leading suppliers of Pharma Grade Activated Carbon produce some of the best Activated Carbon products that are known for their purity and consistent strength. Pharma industry uses Activated Carbon mainly for purification of raw materials and intermediate products that are used in the production of Pharmaceutical products as well as for the purification of the final ...
By Boyce Carbon based in Coimbatore, INDIA.
-
Microbiome Therapeutics for Patients and Physicians
Seres’ microbiome therapeutics represent a transformative new approach to ...
By Seres Therapeutics, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
Microbiome Therapeutics for Clinical Trials
Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. PRISM4, a Phase 3 trial, is designed to serve as the second pivotal trial of ...
By Finch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA).
-
Probiotics: Pharmaceutical-Quality Innovative Solutions
with probiotics, we may help to mitigate and solve upper respiratory, genitourinary or gastrointestinal ...
By Zinereo Pharma based in Pontevedra, SPAIN.
-
Fluid management solutions for acute kidney injury (AKI) sector
Acute Kidney Injury (AKI) is a well-known complication following surgical procedures. So says the weight of clinical evidence. AKI has negative consequences for patient and healthcare provider, leading to worsened long term prospects and heightened costs of care. ...
By Deltex Medical Limited based in Chichester, UNITED KINGDOM.
-
Exhaled Breath and Gas Monitoring Instruments for Gastroenterology industry
in the detection of gastrointestinal disorders such as diagnose lactose intolerance, fructose intolerance, ...
By Bedfont Scientific Limited based in Kent, UNITED KINGDOM.
-
Bioinformatics software solutions for metagenomics sector
Metagenomics is the study of all microbial genomes present in an environment, from the bottom of the sea to inside our own bodies. If you have shotgun NGS sequencing data, Partek provides powerful, easy-to-use analysis tools to characterize microbial ...
By Partek Incorporated based in Chesterfield, MISSOURI (USA).
-
Receptor Antagonist Antiemetic Drug for Gastroenteritis & Gastritis
of the gastrointestinal tract, most commonly caused by viral infection, with symptoms including nausea, vomiting, ...
By RedHill Biopharma Ltd. based in Tel-Aviv, ISRAEL.
-
First Rapid Infuser for Research Grants
including septic shock, anaphylaxis, post-ROSC hypotension, trauma, and obstetric or ...
By 410 Medical based in Durham, NORTH CAROLINA (USA).
-
Klarity - Built Therapeutic Platform Technologies for Gastrointestinal Disease
A defective gastrointestinal (GI) barrier is associated with multiple conditions of high unmet ...
By Kallyope Inc. based in New York City, NEW YORK (USA).
-
Hydraulically Suspended Open-Vane Impeller System for Patient
Heart failure is a chronic condition in which the heart is no longer able to adequately pump blood to meet the demands of the body. It is the progressive weakening of the heart that may impact the function of multiple organs presented as a collection of symptoms. In acute heart failure, the onset of heart failure symptoms and progressive decline can occur rapidly over a short period of ...
By Evaheart, Inc. (EVI) based in Houston, TEXAS (USA).
-
Peri-anal Fistula
Stempeucel® can reduce inflammation, which allows the tissues around the fistula tract to ...
By Stempeutics Research Pvt. Ltd. based in Bangalore, INDIA.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you